Click here to go to the previous page
Antibodies in Drug Discovery and Development and Platform Technologies Supporting the Research Activities
Program Code:
3393
Date:
Wednesday, May 20, 2009
Time:
3:00 PM to 3:30 PM
EST
SPEAKER
(S):
Luca Bolliger, Novimmune
Dominik Escher, ESBATech AG
Michael Rudolf, KENTA BIOTECH
Description
"In the field of antibody drugs, Switzerland has an outstanding pipeline of developments and technology platforms. Moderated by Dominik Escher (CEO ESBATech and Vice President of the Swiss Biotech Association) this session will give an overview to the current status of antibody developments, its research potential and company value creation on an international level."